Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
University of Toronto
$5,000.00
Controlling the Dr. Jekyll and Mr. Hyde personalities of myofibroblasts.
EF 2013-14
Résumé
Repair of tissue injury leaves behind a scar in which the tissue loses vital functions. Scar tissue in organs like the heart can be lethal. In normal repair, local fibroblasts are activated into myofibroblasts to secrete lots of collagen that is then organized by the pulling forces of mature myofibroblasts. Both processes are beneficial but can lead to scarring when repair demands exceed the regenerative potential. To control scarring, it is important to uncouple the production of collagen needed to fill injured tissue space from the contraction of the matrix that disfigures the skin. Evidence from our lab indicates that the mechanical stiffness of the scar controls whether myofibroblasts produce collagen or contract. Contradicting the dogma of a bi-functional myofibroblast, cells seem unable to perform both functions simultaneously in an effective manner.
We hypothesize that production of collagen (fibrogenesis) and development of contractility (myogenesis) of fibroblasts occur in different phases of cell maturation. The aim of this project is to establish culture conditions that arrest skin fibroblasts in defined activity states to pave the road for future studies identifying differential regulatory pathways for both functions. We ultimately aim to be able to selectively induce or repress collagen production and contraction to therapeutically control tissue repair. The research priorities directly relevant to this proposal are 'Tissue Injury, Repair and Replacement' and 'Chronic Disease'. Pathological repair is a leading cause of mortality and a burden on the Canadian Health Care System. No existing therapy is effective to treat fibrosis. In the long term, this research will benefit Canadians affected by organ fibrosis. Enhancing the understanding of cell regulation will inform the design of therapies for fibrocontractive diseases. In particular, anti-fibrosis therapies may be tuned according to the progress of fibrosis and the maturation state of myofibroblasts.
Programme
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
303302
Name
Jani Mitesh
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
Controlling the Dr. Jekyll and Mr. Hyde personalities of myofibroblasts.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Collagen; Contraction; Fibrosis; Myofibroblast; Tissue Repair
Abstract
Repair of tissue injury leaves behind a scar in which the tissue loses vital functions. Scar tissue in organs like the heart can be lethal. In normal repair, local fibroblasts are activated into myofibroblasts to secrete lots of collagen that is then organized by the pulling forces of mature myofibroblasts. Both processes are beneficial but can lead to scarring when repair demands exceed the regenerative potential. To control scarring, it is important to uncouple the production of collagen needed to fill injured tissue space from the contraction of the matrix that disfigures the skin. Evidence from our lab indicates that the mechanical stiffness of the scar controls whether myofibroblasts produce collagen or contract. Contradicting the dogma of a bi-functional myofibroblast, cells seem unable to perform both functions simultaneously in an effective manner.
We hypothesize that production of collagen (fibrogenesis) and development of contractility (myogenesis) of fibroblasts occur in different phases of cell maturation. The aim of this project is to establish culture conditions that arrest skin fibroblasts in defined activity states to pave the road for future studies identifying differential regulatory pathways for both functions. We ultimately aim to be able to selectively induce or repress collagen production and contraction to therapeutically control tissue repair. The research priorities directly relevant to this proposal are 'Tissue Injury, Repair and Replacement' and 'Chronic Disease'. Pathological repair is a leading cause of mortality and a burden on the Canadian Health Care System. No existing therapy is effective to treat fibrosis. In the long term, this research will benefit Canadians affected by organ fibrosis. Enhancing the understanding of cell regulation will inform the design of therapies for fibrocontractive diseases. In particular, anti-fibrosis therapies may be tuned according to the progress of fibrosis and the maturation state of myofibroblasts.
Competitiondate
201401
Approvedterm2
0 yr 3 mths
Pinamesdelim
Jani, Mitesh
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $5,000~ $0~